West Pharmaceutical Services Inc. Stock Slips 7.7%, Underperforms Peers
Dow Jones2026/07/24 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. slipped 7.7% to $328.20 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,411.98 and the Dow Jones Industrial Average rising 0.5% to 51,947.25.
This was the stock's third consecutive day of losses.
West Pharmaceutical Services Inc. closed 15.0% short of its 52-week high of $386.00, which the company achieved on July 23rd.
The stock underperformed when compared to some of its peers, as Abbott Laboratories rose 2.3% to $103.06, Becton Dickinson & Co. rose 2.2% to $156.36, and Baxter International Inc. rose 3.37% to $22.40.
Trading volume totaled 1.5 million, compared to the 50-day average of 769,255.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 24, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
PancakeSwap v3 hosts $3B in spot DEX trading volume for tokenized stocks
Valkyrie joins race for spot bitcoin ETF with Wednesday SEC filing
Bitcoin volatility makes comeback amid ETF-fueled rally
Prime Trust halted deposits, withdrawals after order from Nevada regulator